This inventor holds 2 USPTO granted patents and 3 EPO patents. Top assignees: Vaiomer, Fundacio Institut D'investigacio Biomedica De Girona Dr. Josep Trueta, Università Degli Studi Di Roma "Tor Vergata". Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 3 
1 out of 3 
1 out of 11 Years Active: 2019
Title: Michael Courtney: Innovator in Hepatic Fibrosis and Glycemia Regulation
Introduction
Michael Courtney is a notable inventor based in Lyons, France. He has made significant contributions to the fields of medicine and biotechnology, particularly in the diagnosis and treatment of liver conditions and glycemic regulation. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
One of Michael Courtney's latest patents is a method for diagnosing hepatic fibrosis. This invention focuses on in vitro methods for diagnosing liver fibrosis in subjects suffering from obesity. It also includes methods for selecting subjects for liver biopsy or treatment. Additionally, this patent pertains to screening probiotics, prebiotics, chemical compounds, or biological compounds suitable for preventing and treating liver fibrosis. Another significant patent involves the use of factor Xa inhibitors for regulating glycemia. This invention concerns a factor Xa inhibitor as a medicament for preventing and treating hyperglycemia, impaired glucose tolerance, impaired fasting glucose, insulin resistance, and diabetes.
Career Highlights
Throughout his career, Michael Courtney has worked with various organizations that have contributed to his expertise and innovation. Notable companies include Vaiomer and the University of Rome Tor Vergata. His work in these institutions has allowed him to develop and refine his inventions, making strides in medical research and applications.
Collaborations
Michael has collaborated with esteemed colleagues such as Benjamin Lelouvier and Massimo Federici. These partnerships have fostered an environment of innovation and shared knowledge, further enhancing the impact of his work.
Conclusion
Michael Courtney's contributions to the fields of hepatic fibrosis and glycemia regulation exemplify the importance of innovation in medicine. His patents reflect a commitment to improving health outcomes for individuals suffering from obesity and diabetes. Through his work, he continues to pave the way for advancements in medical technology and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile